Conference Coverage

TVT 2021

July 20, 2021

July 22, 2021

News Conference News TVT 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’

Getting patients on max doses of guideline-directed heart failure therapies is important but also challenging, experts agree.

News

News Conference News TVT 2021

3M TAVR: Minimalist TAVI Pathway Saves Money

Todd Neale

July 26, 2021

News Conference News TVT 2021

Timing of Mitral Surgery After Failed TEER Influences Outcomes

Todd Neale

July 21, 2021

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Todd Neale

July 20, 2021

Late-Breaking Slides

Presentation TVT 2021

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

Presenter: John Forrest

July 20, 2021

Presentation TVT 2021

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Presenter: Mathew Williams

July 20, 2021

Presentation TVT 2021

Early neo2 Registry. Full Core-lab Results of TAVI With the New Acurate neo2 Valve

Presenter: Andreas Ruck

July 20, 2021

Presentation TVT 2021

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Presenter: Saibal Kar

July 21, 2021

All Conference Content

Advertisement

TVT 2021

Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’

News

3M TAVR: Minimalist TAVI Pathway Saves Money

Timing of Mitral Surgery After Failed TEER Influences Outcomes

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

Late-Breaking Slides

Comparison of 1-Year Outcomes After Transcatheter Aortic Valve Replacement in Low-Risk Patients With Severe Bicuspid and Tricuspid Aortic Valve Stenosis

The PARTNER 3 Bicuspid Registry for SAPIEN 3 Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Early neo2 Registry. Full Core-lab Results of TAVI With the New Acurate neo2 Valve

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

@TCTMD

Advertisement

All Conference Content

Advertisement

TVT 2021

News

Late-Breaking Slides

Advertisement

All Conference Content

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content

TVT 2021